The involvement of TNF-α in this process was supported by data obtained by a research group that showed that blocking the TNF-α receptors in an immunogenic mouse melanoma model under anti-PD-1 therapy induced the regression of melanoma in 75% of subjects [82]. The gene discussed is TNF; the disease is melanoma.